Homozygote for mutation c.1204 plus 1G A of the ARSA gene presents with a late-infantile from of metachromatic leukodystrophy and rare MRI white matter lesion type

• Autorzy: Lugowska A , Szymanska K. , Kmiec T. , Tarczynska I. , Czartoryska B. , Tylki-Szymanska A. , Jurkiewicz E.
• Języki publikacji: EN

Abstrakty

EN

The metachromatic leukodystrophy (MLD) - causing mutation c. 1204 + 1G > A damages an intron-exon splice site recognition sequence. This results in a complete loss of enzymatic activity of arylsulfatase A (ARSA) protein molecules. We have found a late-infantile type MLD-patient to be homozygous for this mutation, which was not reported earlier, but is consistent with previous suggestions. Interestingly, the cerebral magnetic resonance imaging (MRI) in this patient displayed linear or punctuate structures radiating in the demyelinated white matter, which resembled the patterns described in Pelizaeus-Merzbacher disease. It should be emphasised that whenever a cerebral MRI demonstrates the 'tigroid' or 'leopard-skin' demyelination pattern not only Pelizaeus-Merzbacher disease, but also metachromatic leukodystrophy diagnosis should be considered; this suggests the necessity of ARSA activity estimations in patients with such specific MRI patterns.

• Wydawca: -
• Czasopismo: Journal of Applied Genetics
• Rocznik: 2005
• Tom: 46
• Numer: 3
• Strony: 337-339
• Opis fizyczny: p.337-339,fig.,ref.

Twórcy

autor

Lugowska A

• Institute of Psychiatry and Neurology, Al.Sobieskiego 9, 02-957 Warsaw, Poland

autor

Szymanska K.

autor

Kmiec T.

autor

Tarczynska I.

autor

Czartoryska B.

autor

Tylki-Szymanska A.

autor

Jurkiewicz E.

Bibliografia

• Berger J, Loeschl B, Bernheimer H, Ługowska A, Tylki-Szymańska A, Gieselmann V, et al. 1997. Occurrence, distribution, and phenotype relations of arylsulfatase A in patients with metachromatic leukodystrophy. Am J Med Genet 69: 335-340.
• Burlina AP, Ferrari V, Boespflug-Tanguy O, Burlina AB, 2001. N-Acetylaspartylglutamate (NAAG) involvement in Pelizaeus-Merzbacher disease. 33rd European Metabolic Group Meeting, Amsterdam, May 18-20, 2001, Book of Abstracts: 37
• Faerber EN, Melvin JJ, Smergel EM, 1999. MRI appearances of metachromatic leukodystrophy. Pediatr Radiol 29: 669-672.
• Figura Von K, Gieselmann V, Jaeken J, 2001. Metachromatic leukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill: 3695-3724.
• Fluharty AL, Fluharty CB, Bohne W, von Figura K, Gieselmann V, 1991. Two new arylsulfatase A (ARSA) mutations in a juvenile metachromatic leukodystrophy (MLD) patient. Am J Hum Genet 49: 1340-50.
• Gieselmann V, 1991. An assay for the rapid detection of the arylsulfatase A pseudodeficiency allele facilitates diagnosis and genetic counseling for metachromatic leukodystrophy. Hum Genet 86: 251-255.
• Kim TS, Kim IO, Kim WS, Choi YS, Lee JY, Kim OW et al. 1997. MR of childhood metachromatic leukodystrophy. AJNR 18: 733-738.
• Lee-Vaupel M, Conzelmann E, 1987. A simple chromogenie assay for arylsulfatase A. Clin Chim Acta 164: 171-180.
• Ługowska A, Tylki-Szymańska A, Berger J, Molzer B, 1997. Elevated sulfatide excretion in compound heterozygotes of metachromatic leukodystrophy and ASA-pseudodeficiency allele. Clin Biochem 30: 325-331.